EZH2 and osteosarcoma: Inhibits cell growth, induces cell cycle arrest and apoptosis. Also inhibits eIF4E and EZH2 activity decreasing its expression levels. Impairs cell migration, invasion and adhesion. In osteosarcoma enhances chemosensitivity.